These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 365857)

  • 1. Double blind study of the effects of diphenylhydantoin sodium on diabetic neuropathy.
    Chadda VS; Mathur MS
    J Assoc Physicians India; 1978 May; 26(5):403-6. PubMed ID: 365857
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical trial of isaxonine in diabetic neuropathies (author's transl)].
    Augustin P; Rathery M
    Nouv Presse Med; 1982 Apr; 11(16):1265-8. PubMed ID: 7048246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of diabetic neuropathy with diphenylhydantoin.
    Ellenberg M
    N Y State J Med; 1968 Oct; 68(20):2653-5. PubMed ID: 4300475
    [No Abstract]   [Full Text] [Related]  

  • 4. [Imipramine in the treatment of painful diabetic neuropathy of the extremities].
    Kvinesdal B; Molin J; Frøland A; Gram LF
    Ugeskr Laeger; 1983 Sep; 145(39):3018-9. PubMed ID: 6359618
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of cyclandelate on diabetic peripheral neuropathy.
    Canal N; Comi G; Marchettini P; Pozza G
    Br J Clin Pract Suppl; 1984; 34():62-8. PubMed ID: 6430326
    [No Abstract]   [Full Text] [Related]  

  • 6. Antidepressive agents in the treatment of diabetic neuropathy.
    Kvinesdal B; Molin J; Frøland A; Gram LF
    Clin Physiol; 1985; 5 Suppl 5():97-100. PubMed ID: 3914393
    [No Abstract]   [Full Text] [Related]  

  • 7. Nortriptyline and fluphenazine in the symptomatic treatment of diabetic neuropathy. A double-blind cross-over study.
    Gomez-Perez FJ; Rull JA; Dies H; Rodriguez-Rivera GJ; Gonzalez-Barranco J; Lozano-Castañeda O
    Pain; 1985 Dec; 23(4):395-400. PubMed ID: 3911140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind comparison of topical capsaicin and oral amitriptyline in painful diabetic neuropathy.
    Biesbroeck R; Bril V; Hollander P; Kabadi U; Schwartz S; Singh SP; Ward WK; Bernstein JE
    Adv Ther; 1995; 12(2):111-20. PubMed ID: 10150323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressants in the treatment of diabetic neuropathy symptoms. Pharmacodynamic, -kinetic, and -genetic aspects.
    Sindrup SH
    Dan Med Bull; 1994 Feb; 41(1):66-78. PubMed ID: 8187566
    [No Abstract]   [Full Text] [Related]  

  • 10. Nortriptyline-fluphenazine vs. carbamazepine in the symptomatic treatment of diabetic neuropathy.
    Gómez-Pérez FJ; Choza R; Ríos JM; Reza A; Huerta E; Aguilar CA; Rull JA
    Arch Med Res; 1996; 27(4):525-9. PubMed ID: 8987189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenytoin in the treatment of diabetic symmetrical polyneuropathy.
    Saudek CD; Werns S; Reidenberg MM
    Clin Pharmacol Ther; 1977 Aug; 22(2):196-9. PubMed ID: 328209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imipramine treatment of painful diabetic neuropathy.
    Kvinesdal B; Molin J; Frøland A; Gram LF
    JAMA; 1984 Apr; 251(13):1727-30. PubMed ID: 6366276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of disease characteristics on the efficacy of duloxetine in diabetic peripheral neuropathic pain.
    Ziegler D; Pritchett YL; Wang F; Desaiah D; Robinson MJ; Hall JA; Chappell AS
    Diabetes Care; 2007 Mar; 30(3):664-9. PubMed ID: 17327338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capsaicin: a therapeutic option for painful diabetic neuropathy.
    Basha KM; Whitehouse FW
    Henry Ford Hosp Med J; 1991; 39(2):138-40. PubMed ID: 1890008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lacosamide in painful diabetic peripheral neuropathy: a phase 2 double-blind placebo-controlled study.
    Rauck RL; Shaibani A; Biton V; Simpson J; Koch B
    Clin J Pain; 2007 Feb; 23(2):150-8. PubMed ID: 17237664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tegretol in the treatment of diabetic neuropathy.
    Wilton TD
    S Afr Med J; 1974 Apr; 48(20):869-72. PubMed ID: 4597907
    [No Abstract]   [Full Text] [Related]  

  • 17. A multicenter, double-blind, safety study of QR-333 for the treatment of symptomatic diabetic peripheral neuropathy. A preliminary report.
    Valensi P; Le Devehat C; Richard JL; Farez C; Khodabandehlou T; Rosenbloom RA; LeFante C
    J Diabetes Complications; 2005; 19(5):247-53. PubMed ID: 16112498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial.
    Ziegler D; Ametov A; Barinov A; Dyck PJ; Gurieva I; Low PA; Munzel U; Yakhno N; Raz I; Novosadova M; Maus J; Samigullin R
    Diabetes Care; 2006 Nov; 29(11):2365-70. PubMed ID: 17065669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ganglioside therapy in diabetic neuropathy.
    Horowitz SH
    Muscle Nerve; 1986; 9(6):531-6. PubMed ID: 3526143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duloxetine (Cymbalta) for diabetic neuropathic pain.
    Med Lett Drugs Ther; 2005 Aug 15-29; 47(1215-1216):67-8. PubMed ID: 16103866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.